Composite endpoint (including all‐cause mortality, non‐fatal myocardial infarction and/or any new stroke assessed at 30 days after surgery) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in composite endpoint (including all‐cause mortality, non‐fatal… compared with no RIPC (moderate certainty).
1 finding from 1 review
Early postoperative mortality Deaths in the 30 days after surgery · patients with refractory angina
Transmyocardial laser revascularization showed no clear difference in early postoperative mortality Deaths in the 30 days after surgery compared with medical treatment (high certainty).
1 finding from 1 review
All‐cause mortality · paediatric patients following heart surgery
Prophylactic levosimendan showed no clear difference in mortality compared with standard treatment (low certainty).
1 finding from 1 review
Intervention not reported
Mortality · patients undergoing cardiac surgery
The intervention showed no clear difference in mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
30‐day mortality4 · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention showed no clear difference in 30‐day mortality4 (low certainty).
1 finding from 1 review
Mortality (30‐day) · cardiac surgery for the treatment of non‐surgical bleeding
It is very uncertain whether PCC changes mortality (30‐day) compared with FVIIa (very low certainty).
1 finding from 1 review
Mortality (30‐day) · cardiac surgery for the treatment of non‐surgical bleeding
PCC showed no clear difference in mortality (30‐day) compared with standard treatment (moderate certainty).
1 finding from 1 review
All‐cause mortality · adults undergoing cardiac surgery with cardiopulmonary bypass
It is very uncertain whether high changes all‐cause mortality compared with low blood pressure target (very low certainty).
1 finding from 1 review
All‐cause mortality · adults after heart valve surgery
It is very uncertain whether exercise changes all‐cause mortality compared with no exercise (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Cardiovascular mortality · adults after heart valve surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality within the longest · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in all‐cause mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
In‐hospital postoperative mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in in‐hospital postoperative mortality compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in cardiovascular mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Short‐term mortality (up to 30 days) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Mortality within the longest · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids showed no clear difference in all‐cause mortality (during the index hospital admission, or within… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Intervention not reported
Hospital or 30‐day mortality
It is very uncertain whether the intervention changes hospital or 30‐day mortality (very low certainty).
1 finding from 1 review